Overactive bladder is a symptom complex consisting of bothersome storage urinary
symptoms that is highly prevalent among both sexes and has a significant impact on quality …

Background Few randomized controlled trials evaluate the long-term efficacy and safety of
pharmacotherapy for overactive bladder (OAB). This network meta-analysis compares the …

The present article is an abridged English translation of the Japanese Clinical Guidelines for
Female Lower Urinary Tract Symptoms (second edition), published in September 2019 …

Purpose This cohort study evaluates therapeutic efficacy and adverse events (AEs) of
various overactive bladder (OAB) medications for patients with central nervous system …

To assess the pharmacologically relevant and selective muscarinic receptor occupancy in
the bladder mucosa, we considered not only plasma drug concentrations but also urinary …

Objective: To evaluate the cost-effectiveness of solifenacin 5 mg/day versus other oral
antimuscarinic agents used for overactive bladder (OAB) from a UK National Health Service …

Background Patients with overactive bladder may cycle through different antimuscarinic
medications even though there is limited evidence to support this approach. Objective To …

摘要目的探讨骶神经根磁刺激联合索利那新治疗女性难治性膀胱过度活动症(OAB) 的临床效果.
方法2017 年1 月至12 月, 120 例难治性OAB 患者随机分为骶神经根磁刺激组(n= 40) …

Background: This study aimed to evaluate the clinical efficacy of Yun-type optimized pelvic
floor training therapy for middle-aged women with severe overactive bladder (OAB) …

Abstract Background: Solefinacin and Tolterodine are new generation antimuscarinics
claimed to have bladder specific action and less adverse effect like dry mouth. The objective …